The global medical rehabilitation robot market is expected to grow at a CAGR of around 12% during the forecast period of 2023-2028 and was valued at around US$ 324 million in 2022.
A medical rehabilitation robot, or a rehab robot, is a robotic device designed to assist in the rehabilitation process of individuals with disabilities or those recovering from injuries or surgeries. These robots are used in physical therapy and rehabilitation settings to provide patient assistance, support, and therapy.
Disabilities and chronic illnesses like stroke, spinal cord damage, Parkinson’s disease, and orthopedic issues are becoming more common. In order to help patients heal, rehabilitate, and enhance their functional capacities, medical rehabilitation robots offer therapeutic interventions and assistive gadgets.
Due to the sophisticated technologies and intricate engineering required for their development, medical rehabilitation robots are frequently pricey. Particularly in healthcare institutions with tight budgets, the exorbitant cost of these robots may prevent widespread deployment. Widespread adoption may face difficulties related to cost-effectiveness and reimbursement, particularly in areas with constrained financial resources.
Increasing Focus on Rehabilitation and Physical Therapy Driving Medical Rehabilitation Robots Demand
Physical therapy and rehabilitation are increasingly being recognized for their value in enhancing patient outcomes and quality of life. Medical rehabilitation robots provide controlled and dependable movements, reliable data collecting, and individualized treatment regimens to supplement conventional therapy methods. These machines can help therapists conduct focused and rigorous therapy, which will produce greater results.
Globally, governments and healthcare institutions are becoming more aware of the potential advantages of medical rehabilitation robots. They are launching legislation and funding schemes to assist these technologies’ study, creation, and acceptance. Government programs encourage partnerships between academic institutions, business leaders, and healthcare providers, stimulating the market. These are the major driving factors that are propelling the medical rehabilitation robot market.
Request for Sample and Scope of the Study
North America Significantly Drives Global Medical Rehabilitation Robot Market Growth
Medical rehabilitation robots have seen substantial market growth in North America, which is mostly due to the region’s developed healthcare infrastructure, technical improvements, and high healthcare spending. Due to its sizable patient population and significant investment in healthcare research and development, the US in particular plays a significant role in the global medical rehabilitation robot growth. A study that appeared in the “Journal of Neuro Engineering and Rehabilitation” revealed that between 2,49,000 and 3,63,000 Americans struggle with the effects of spinal cord injuries (SCI), and that 17,730 new SCI cases occur each year.
Europe will show significant growth in the global medical rehabilitation robot throughout the forecast period. The area is distinguished by a rising elderly population and encouraging government programs encouraging the adoption of cutting-edge medical technologies. In terms of market share, nations like Germany, the U.K., and France have been in the lead.
Market Structure and Competitive Landscape
The global medical rehabilitation robot market is fragmented in nature with the presence of various players operating in the market.
Some of the prominent players operating in the medical rehabilitation robot market include Ekso Bionics Holdings Inc., AlterG, Inc., Bionik Laboratories Corp., Cyberdyne Inc., ReWalk Robotics, Instead Technologies Ltd., Hocoma AG, Fourier Intelligence, Tyromotion Gmbh, Toyota Motor Corporation, BeatBots LLC, Bioxtreme, Rex Bionics Inc., LEADERS REHAB ROBOT Co. Ltd among others.
These players are majorly regional players and maintain a healthy competitive environment. Following are some of the expansions of the medical rehabilitation robot market:
- In November 2022: H Robots, launched new cooperation for a fast-expanding robotics manufacturing business specializing in cutting-edge rehabilitation solutions. Rehabmart (Medical Device Distributor) is now selling its FDA-approved physical therapy gadget reblessTM accessible on their website rehabmart.com.
Key Market Segmentation
RationalStat has segmented the global medical rehabilitation robot market based on product, extremity, therapy, patient, application, end user, and region.
- By Product
- Exoskeletons
- Therapeutic/Assistive
- By Extremity
- Upper Extremity
- Arm
- Wrist
- Shoulder
- Elbow
- Lower Extremity
- Upper Extremity
- By Therapy
- Limb Mobility
- Gait
- Sensory
- By Patient
- Adults
- Pediatric
- By Application
- Neurorehabilitation
- Physical Rehabilitation
- Others
- By End User
- Hospitals
- Wellness Centers
- Rehabilitation Centers
- Homecare
- By Region
- North America
- US
- Canada
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Western Europe
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Rest of Eastern Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- ASEAN (Indonesia, Vietnam, Malaysia, etc.)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- South Africa
- Turkey
- Rest of the Middle East & Africa
- North America
To customize reports as per your needs, speak to our analyst
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Secondary Sources
- Annual reports, company filings, investor presentations, product catalogs, and company documents
- Industry and market-related documents available in the public domain
- Paid database including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, and Thomson Reuters, among others
- Whitepapers, research papers, and industry blogs.
Why Buy this Report?
The report is intended for manufacturers, raw material suppliers, third-party distributors, construction industry players, government organizations, research institutes, educational organizations, regulatory agencies, and market research firms, among others. The report provides an in-depth analysis of market size, consumption patterns, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions.
Frequently Asked Questions (FAQs)
The global medical rehabilitation robot market is anticipated to grow at a CAGR of approximately 12% during the forecast period 2023-2028.
The global medical rehabilitation robot market is estimated at US$ 324 million in 2022.
Rising prevalence of disabilities and chronic conditions driving the need for medical rehabilitation robots.
North America holds the major share of the global medical rehabilitation robot market.
Leading Companies operating in the global medical rehabilitation robot market include Ekso Bionics Holdings Inc., AlterG, Inc., Bionik Laboratories Corp., Cyberdyne Inc., ReWalk Robotics, Instead Technologies Ltd., Hocoma AG, Fourier Intelligence, Tyromotion Gmbh, Toyota Motor Corporation, BeatBots LLC, Bioxtreme, Rex Bionics Inc., and LEADERS REHAB ROBOT Co. Ltd., etc.